Please use this identifier to cite or link to this item:
https://doi.org/10.1136/bmjopen-2020-044497
Title: | Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol | Authors: | Tang, Benjamin Shojaei, Maryam Wang, Ya Nalos, Marek Mclean, Anthony Afrasiabi, Ali Kwan, Tim N KUAN WIN SEN Zerbib, Yoann Herwanto, Velma Gunawan, Gunawan Bedognetti, Davide Zoppoli, Gabriele Ballestrero, Alberto Rinchai, Darawan Cremonesi, Paolo Bedognetti, Michele Matejovic, Martin Karvunidis, Thomas Macdonald, Stephen PJ Cox, Amanda J West, Nicholas P Cripps, Allan William Schughart, Klaus Maria, Andrea de Chaussabel, Damien Iredell, Jonathan Weng, Stephen |
Issue Date: | 6-Jan-2021 | Publisher: | BMJ | Citation: | Tang, Benjamin, Shojaei, Maryam, Wang, Ya, Nalos, Marek, Mclean, Anthony, Afrasiabi, Ali, Kwan, Tim N, KUAN WIN SEN, Zerbib, Yoann, Herwanto, Velma, Gunawan, Gunawan, Bedognetti, Davide, Zoppoli, Gabriele, Ballestrero, Alberto, Rinchai, Darawan, Cremonesi, Paolo, Bedognetti, Michele, Matejovic, Martin, Karvunidis, Thomas, Macdonald, Stephen PJ, Cox, Amanda J, West, Nicholas P, Cripps, Allan William, Schughart, Klaus, Maria, Andrea de, Chaussabel, Damien, Iredell, Jonathan, Weng, Stephen (2021-01-06). Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol. BMJ Open 11 (1) : e044497. ScholarBank@NUS Repository. https://doi.org/10.1136/bmjopen-2020-044497 | Abstract: | Introduction Accurate triage is an important first step to effectively manage the clinical treatment of severe cases in a pandemic outbreak. In the current COVID-19 global pandemic, there is a lack of reliable clinical tools to assist clinicians to perform accurate triage. Host response biomarkers have recently shown promise in risk stratification of disease progression; however, the role of these biomarkers in predicting disease progression in patients with COVID-19 is unknown. Here, we present a protocol outlining a prospective validation study to evaluate the biomarkers’ performance in predicting clinical outcomes of patients with COVID-19. Methods and analysis This prospective validation study assesses patients infected with COVID-19, in whom blood samples are prospectively collected. Recruited patients include a range of infection severity from asymptomatic to critically ill patients, recruited from the community, outpatient clinics, emergency departments and hospitals. Study samples consist of peripheral blood samples collected into RNA- preserving (PAXgene/Tempus) tubes on patient presentation or immediately on study enrolment. Real- time PCR (RT- PCR) will be performed on total RNA extracted from collected blood samples using primers specific to host response gene expression biomarkers that have been previously identified in studies of respiratory viral infections. The RT- PCR data will be analysed to assess the diagnostic performance of individual biomarkers in predicting COVID-19- related outcomes, such as viral pneumonia, acute respiratory distress syndrome or bacterial pneumonia. Biomarker performance will be evaluated using sensitivity, specificity, positive and negative predictive values, likelihood ratios and area under the receiver operating characteristic curve. Ethics and dissemination This research protocol aims to study the host response gene expression biomarkers in severe respiratory viral infections with a pandemic potential (COVID-19). It has been approved by the local | Source Title: | BMJ Open | URI: | https://scholarbank.nus.edu.sg/handle/10635/185423 | ISSN: | 2044-6055 | DOI: | 10.1136/bmjopen-2020-044497 |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
2021 PREDICT-19 Protocol - BMJ Open.pdf | Published version | 335.82 kB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.